Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-11-07 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
113年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 113年09月30日 (which corresponds to the third quarter of the fiscal year 2024). The presence of detailed financial statement data (assets, liabilities, equity) indicates this is a financial report rather than an announcement or summary. The length is 4403 characters, which is relatively short but contains substantive financial data. The document is a quarterly financial report (interim report) given the date references to a quarter-end and the detailed financial figures. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2024
2024-11-07 Chinese
公告本公司任命全球產品組合管理副總經理
Board/Management Information Classification · 100% confidence The document is a short announcement (758 characters) about the appointment of a new Vice President of Global Product Portfolio Management at the company 美時 (stock code 1795). It details the name, position, effective date, and background of the new appointee. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content clearly relates to a change in senior management personnel. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not a report but an announcement of a management change. Therefore, the correct classification is MANG with high confidence.
2024-11-07 Chinese
公告本公司任命營運長
Board/Management Information Classification · 100% confidence The document is a short announcement (727 characters) about the appointment of a new Chief Operating Officer (營運長) at the company 美時 (company code 1795). It includes details such as the name of the new appointee, the effective date, and the reason for the change (職務調整). There is no financial data, no mention of financial results, reports, or regulatory filings beyond this personnel change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-11-07 Chinese
公告本公司人事異動
Board/Management Information Classification · 100% confidence The document is a company announcement regarding a personnel change, specifically a management position adjustment (副總經理, Vice General Manager). It includes details about the old position holder, the nature of the change (職務調整, job adjustment), and the effective date. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the personnel change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-11-07 Chinese
公告本公司董事會決議通過113年第三季財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a formal announcement from the company (1795 美時) regarding the board of directors' approval of the third quarter financial report for the fiscal period from January 1 to September 30, 113 (Taiwan calendar year). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity. The document is short (921 characters) and primarily serves as a notification of the board's resolution to approve the quarterly financial report rather than the full detailed report itself. This fits the definition of an Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year. Therefore, the classification is IR with high confidence. 9M 2024
2024-11-07 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing data on fund loans and guarantee information for the current and previous month, including limits and balances. The content is numerical and relates to financial status but is very brief (633 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. Given the short length and nature of the data, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-11-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.